John Hess Trims Another $36M of CVX Post-Merger; 658K Shares Left

John Hess — the former CEO of Hess Corporation and the son of founder Leon Hess — filed Form 4 with the SEC last week disclosing the open-market sale of 194,000 shares of Chevron (CVX) for roughly $36 million on May 6, 2026. The three reported transactions priced between $183.90 and $185.21 a share. After the sale John Hess holds 658,045 CVX shares in his reporting capacity — down from 1,403,045 shares last August and roughly half the position he held after the original Hess-Chevron deal closed in July 2024.

The story is not the $36 million headline. The story is the pace and the shape of the wind-down. John Hess's CVX position is the residual of one of the largest individual-holder windfalls in 2020s energy M&A history: the Hess Corp shares he and family-related entities owned were converted at the merger into Chevron stock, leaving John Hess as one of CVX's largest non-institutional individual holders. The pattern of sales since the merger closed is what tells you whether this is forced disposition (estate planning, concentrated-position risk management) or a discretionary view on Chevron's outlook.

The sale pattern at a glance

Over roughly nine months, the trimming totals to ~1.12 million CVX shares sold for ~$178 million. The May 6 transactions are the smallest single-event tranche of the three. The November 2025 sale was nearly twice as large in share count and dollar terms, and the August 2025 sale before it was bigger still. Looking at the trajectory: 1,778,045 → 1,403,045 → 853,045 → 658,045. The trim rate is slowing in share-count terms but holding up in dollar terms because CVX is moving from $158 to $185 across the window. That is consistent with a price-target wind-down rather than a calendar-driven program.

How John Hess became this big a CVX holder

The legacy: Hess Corporation was founded by Leon Hess in 1933 and remained majority-influenced by the Hess family through John Hess's CEO tenure from 1995 to 2024. The merger consideration paid by Chevron in the July 2024 closing was approximately 1.025 CVX shares per HES share, valuing John Hess's then-direct stake of ~5.4 million HES shares (per his last Form 4 filings as Hess CEO) at a CVX-share number broadly consistent with the August 2024 starting line of 1.78M CVX shares we can reconstruct from the post-merger sales pattern. He also retained a board seat at Chevron immediately post-merger, though his current officer/director designation on the most recent Form 4 (filed as a non-officer, non-director, sub-10% holder) suggests he has since stepped off the board or otherwise no longer holds those formal roles at CVX.

This matters because the SEC reporting status changes how the market reads the filing. As a sub-10% non-affiliate holder, John Hess's Form 4 sales are technically not insider-status filings in the strict sense, but he was a Section 16 reporting person and the legacy filings continue. The roughly 0.034% of Chevron's total shares outstanding represented by his remaining 658K stake (CVX has ~1.94 billion shares outstanding) puts him well outside the activist-disclosure range, but well inside the "watch-list for any large block trades" range for desks that trade CVX daily.

Reading the timing

The May 6 sale clustered around CVX's 2026-Q1 earnings results on May 2. Chevron beat consensus on adjusted earnings but missed slightly on Permian production guidance, and the stock ran from $176 the day before earnings to a $187 intraday high on May 5 before settling around $185 on May 6 — the day of the sale. Selling into post-earnings strength is a textbook pattern for plan-driven dispositions but is also the rational way to discretionarily exit a concentrated position. Without a 10b5-1 plan footnote on the filing — and there is none visible — the safest read is that this was a discretionary trim taken into earnings strength, not a prearranged plan tranche.

For comparison: the November 2025 sale clustered around the Q3 2025 results on November 1, and the August 2025 sale clustered around Q2 results on August 1. Each tranche has landed in the first or second week of the month following a Chevron earnings print, with the price level appearing to be the gating factor.

The remaining position is still meaningful

At Friday's roughly $185 close, John Hess's residual 658,045 shares are worth approximately $121.7 million. That is no longer a Section 13D-amendment-relevant position relative to Chevron's total float, but it is still a multi-decade family wealth concentration in a single name. The pattern of wind-down so far suggests the eventual landing zone for the position is somewhere between zero and the threshold at which the family complex finds the residual exposure acceptable for inheritance planning. Either of those endpoints implies further selling.

For the holder-side context, the CVX stock page shows the full institutional ownership map. The institutional book is dominated by the usual large-cap energy index complex; John Hess's residual is one of the very few individual holders large enough to register against that backdrop.

The 13G beneficial-ownership cross-check

It is worth noting that John Hess's most recent Schedule 13G/A filing dated 2025-02-14 reported beneficial ownership of 26,502,061 shares at 8.58% of Hess Corp. That filing predates the merger close-out and references the legacy Hess Corp entity. The current Form 4 sales are filed against the CVX issuer, and the Section 13G beneficial-ownership disclosure mechanics for the residual CVX position post-merger would be at the Chevron entity level. We do not see a current 13G filing at Chevron from John Hess for the post-merger residual, which is consistent with the position now sitting below the 5% disclosure threshold at CVX scale (Chevron has 1.94 billion shares outstanding; 5% would be 97 million shares).

What to watch from here

1. Chevron Q2 2026 earnings, scheduled for late July 2026. If the May 6 / November 2025 / August 2025 pattern holds, the next John Hess sale tranche will land in the first or second week of August 2026 if CVX is trading above the prior tranche's price level.
2. Any new 144 filings. Form 144 (notice of proposed sale of restricted/control securities) gives advance warning of larger block dispositions. Subscribe to the alerts feed for CVX-tagged 144 filings.
3. A 13G crossing would re-enter the activist-disclosure register. The residual 658K shares are well below the threshold, so this is a low-probability event — but worth keeping on the radar if Chevron does a large buyback program that reduces share count and changes the percentage math.

For E-E-A-T citation, the underlying Form 4 filings are publicly indexed on John Hess's EDGAR page (reporter CIK 0001087997). The May 6 sale was reported under accession number 0000093410-26-000117, filed against Chevron's issuer CIK 0000093410. Readers tracking the full Hess-to-Chevron transition can find the historical Form 4 filings from his Hess CEO years on John Hess's insider profile; the explainer on reading 10b5-1 plan footnotes is the right primer for distinguishing this kind of discretionary sale from prearranged plan tranches.